KA/EN
Register
Medicines reference
Search
Search
Product

Aurobindo Amoxicillin/Clavulanate

Favourites

Amoxicillin + Clavulanic Acid · Aurobindo Pharma Limited

3 forms: coated tablet, suspension. In force in Georgia: 3 of 3 (veterinary register).

Forms and doses3 of 3 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Choose species and weight; the matching row will be highlighted.
Form Species Dose Frequency Georgia
62.5 mg/ml oral suspension, Suspension · Cat Cat 1 ml (15 ml)
Add exactly 14 ml water to the 15 ml bottle and shake vigorously. Give 1 ml every 12 hours. Refrigerate after reconstitution and discard unused suspension after 10 days. Treat only a susceptible bacterial infection under veterinary direction. Contraindicated after penicillin/cephalosporin allergy; pregnancy/breeding safety is not established.
 · twice daily; duration depends on the susceptible infection		 twice daily; duration depends on the susceptible infection Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ამოქსიცილინის და კალიუმის კლავულანატის პერორალური წვეთების მოსამზადებელი სუსპენზიისთვის 62.5მგ
№ 287-11
Verified on: 21 Oct 2026
62.5 mg/ml oral suspension, Suspension · Dog Dog 1 ml per 4.536 kg
Add exactly 14 ml water to the 15 ml bottle and shake vigorously. Give 1 ml per 10 lb (4.54 kg) every 12 hours. Refrigerate after reconstitution and discard unused suspension after 10 days. Treat only a susceptible bacterial infection under veterinary direction. Contraindicated after penicillin/cephalosporin allergy; pregnancy/breeding safety is not established.
 · twice daily; duration depends on the susceptible infection		 twice daily; duration depends on the susceptible infection Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ამოქსიცილინის და კალიუმის კლავულანატის პერორალური წვეთების მოსამზადებელი სუსპენზიისთვის 62.5მგ
№ 287-11
Verified on: 21 Oct 2026
Details: pack, label wording, sources, registration

Aurobindo Amoxicillin/Clavulanate 62.5 mg/ml oral suspension, Suspension

15 ml for dogs and cats
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Full dog label transferred from Clavamox Drops: susceptible skin, soft-tissue and periodontal bacterial infections treated with 62.5 mg/ml oral suspension
6.8/10
Situational / acceptable
vetman assessment

Aurobindo Amoxicillin/Clavulanate

62.5 mg/ml oral suspension, 15 ml for dogs and cats
Assessed clinical scopeDog · Full dog label transferred from Clavamox Drops: susceptible skin, soft-tissue and periodontal bacterial infections treated with 62.5 mg/ml oral suspension · By mouth
Care settingOutpatient antimicrobial treatment after diagnosis, with comparator-derived dosing and the unresolved exact-pack conflict visible
vetman score 6.8/10 Situational / acceptable
Evidence confidence: Low Georgia: Yes, veterinary · № 287-11 · Verified on 21 Oct 2026

The pharmacology is credible, but this exact presentation is only situationally acceptable until its 15-versus-30 ml identity conflict and exact instructions are resolved. Verify the physical pack and manufacturer leaflet before prescribing.

Regulatory and scientific credibility5.5/10

The exact Aurobindo product is actively registered in Georgia, but its bilingual register row conflicts on 30 ml versus 15 ml and no exact public SPC was found; the clinical instructions come from Clavamox Drops, not this manufacturer.

Clinical efficacy7.5/10

Amoxicillin/clavulanate suspension is established for susceptible canine skin, soft-tissue and periodontal infections, but exact-product efficacy is indirect and treatment must follow diagnosis and susceptibility.

Safety and tolerability7.5/10

Class and comparator safety are established, but exact-product and reproductive safety documentation are limited; gastrointestinal reactions and beta-lactam allergy remain central.

Clinical practicality6.5/10

Liquid dosing can suit small dogs, but exact reconstitution, vigorous shaking, refrigeration, ten-day discard and the unresolved bottle-volume conflict materially increase error and waste risk.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use after penicillin or cephalosporin hypersensitivity; serious cross-reactions are possible.
  • The Georgian register conflicts on a 30 ml versus 15 ml bottle and no exact Aurobindo SPC is public; verify the physical product before use.
  • The displayed reconstitution and dose come from Clavamox Drops, not an exact Aurobindo instruction; do not transfer them without pack verification.
  • Treat only a diagnosed susceptible bacterial infection; use culture and susceptibility testing whenever feasible.
  • Comparator handling requires exact water addition, vigorous shaking, refrigeration and disposal after 10 days.
  • Safety in pregnant or breeding animals is not established in the comparator label.
  • Monitor anorexia, lethargy, vomiting, diarrhoea and allergic reactions; reassess inadequate response rather than extending empirically.
Assessment sources
  1. FDA NADA 055-1012019
  2. Georgia NFA register 20262026
  3. ISCAID 20252025
  4. ISCAID urinary 20192019
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Full cat label transferred from Clavamox Drops: susceptible skin, soft-tissue and urinary bacterial infections treated with 62.5 mg/ml oral suspension
6.9/10
Situational / acceptable
vetman assessment

Aurobindo Amoxicillin/Clavulanate

62.5 mg/ml oral suspension, 15 ml for dogs and cats
Assessed clinical scopeCat · Full cat label transferred from Clavamox Drops: susceptible skin, soft-tissue and urinary bacterial infections treated with 62.5 mg/ml oral suspension · By mouth
Care settingOutpatient antimicrobial treatment after confirming bacterial disease, with comparator-derived dosing and the unresolved exact-pack conflict visible
vetman score 6.9/10 Situational / acceptable
Evidence confidence: Low Georgia: Yes, veterinary · № 287-11 · Verified on 21 Oct 2026

The fixed feline dose is convenient, but this exact presentation remains situational until the 15-versus-30 ml identity conflict and exact manufacturer instructions are resolved. Confirm bacterial disease and verify the physical pack.

Regulatory and scientific credibility5.5/10

The exact Aurobindo product is actively registered in Georgia, but its bilingual register row conflicts on 30 ml versus 15 ml and no exact public SPC was found; the clinical instructions come from Clavamox Drops.

Clinical efficacy7.5/10

The class is established for susceptible feline skin, soft-tissue and urinary infections, but most young cats with lower urinary signs are not bacterially infected and exact-product efficacy evidence is indirect.

Safety and tolerability7.5/10

Class and comparator safety are established, but exact-product and reproductive safety documentation are limited; gastrointestinal reactions and beta-lactam allergy remain central.

Clinical practicality7.0/10

A fixed 1 ml feline dose is simple, but exact reconstitution, vigorous shaking, refrigeration, ten-day discard and the unresolved bottle-volume conflict add substantial handling risk.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use after penicillin or cephalosporin hypersensitivity; serious cross-reactions are possible.
  • The Georgian register conflicts on a 30 ml versus 15 ml bottle and no exact Aurobindo SPC is public; verify the physical product before use.
  • The displayed reconstitution and dose come from Clavamox Drops, not an exact Aurobindo instruction; do not transfer them without pack verification.
  • Treat only a diagnosed susceptible bacterial infection; use culture and susceptibility testing whenever feasible.
  • Comparator handling requires exact water addition, vigorous shaking, refrigeration and disposal after 10 days.
  • Safety in pregnant or breeding animals is not established in the comparator label.
  • Monitor anorexia, lethargy, vomiting, diarrhoea and allergic reactions; reassess inadequate response rather than extending empirically.
Assessment sources
  1. FDA NADA 055-1012019
  2. Georgia NFA register 20262026
  3. ISCAID 20252025
  4. ISCAID urinary 20192019
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Amoxicillin50 mg/ml Clavulanic Acid12.5 mg/ml
Formulation Type
Suspension
Administration route
oral
Manufacturer
Aurobindo Pharma Limited · India
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ამოქსიცილინის და კალიუმის კლავულანატის პერორალური წვეთების მოსამზადებელი სუსპენზიისთვის 62.5მგ
№ 287-11
Verified on: 21 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
DoseSpeciesWeightRouteFrequencySource
1 ml (15 ml)
Add exactly 14 ml water to the 15 ml bottle and shake vigorously. Give 1 ml every 12 hours. Refrigerate after reconstitution and discard unused suspension after 10 days. Treat only a susceptible bacterial infection under veterinary direction. Contraindicated after penicillin/cephalosporin allergy; pregnancy/breeding safety is not established.
 Cat Any weight By mouth twice daily; duration depends on the susceptible infection
FDA NADA 055-101
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Clavamox Drops - FDA NADA 055-101
DailyMed veterinary label, 2019
1 ml per 4.536 kg
Add exactly 14 ml water to the 15 ml bottle and shake vigorously. Give 1 ml per 10 lb (4.54 kg) every 12 hours. Refrigerate after reconstitution and discard unused suspension after 10 days. Treat only a susceptible bacterial infection under veterinary direction. Contraindicated after penicillin/cephalosporin allergy; pregnancy/breeding safety is not established.
 Dog Any weight By mouth twice daily; duration depends on the susceptible infection
FDA NADA 055-101
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Clavamox Drops - FDA NADA 055-101
DailyMed veterinary label, 2019
62.5 mg veterinary tablets, Coated tablet · Cat Cat 1 tablet
Cats: one complete 62.5 mg tablet every 12 hours. Treat only a susceptible bacterial infection under veterinary direction. Contraindicated after penicillin/cephalosporin allergy; pregnancy/breeding safety is not established. Reported reactions include anorexia, lethargy, vomiting and diarrhoea.
 · twice daily; duration depends on the susceptible infection		 twice daily; duration depends on the susceptible infection Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: მოქსიცილინის და კალიუმის კლავულანატის ტაბლეტები 62.5მგ
№ 286-11
Verified on: 21 Oct 2026
62.5 mg veterinary tablets, Coated tablet · Dog Dog 1 tablet per 4.536 kg
Give one whole tablet per 10 lb (4.54 kg) body weight every 12 hours (6.25 mg/lb, about 13.78 mg/kg combined active ingredients). The tablet is coated and unscored; the calculator must warn when the exact result requires division. Treat only a susceptible bacterial infection under veterinary direction. Contraindicated after penicillin/cephalosporin allergy; pregnancy/breeding safety is not established. Reported reactions include anorexia, lethargy, vomiting and diarrhoea.
 · twice daily; duration depends on the susceptible infection		 twice daily; duration depends on the susceptible infection Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: მოქსიცილინის და კალიუმის კლავულანატის ტაბლეტები 62.5მგ
№ 286-11
Verified on: 21 Oct 2026
Details: pack, label wording, sources, registration

Aurobindo Amoxicillin/Clavulanate 62.5 mg veterinary tablets, Coated tablet

210 tablets for dogs and cats
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Full dog label transferred from the same-strength FDA reference generic: susceptible skin, soft-tissue and periodontal bacterial infections treated with 62.5 mg amoxicillin/clavulanate tablets
7.1/10
Good
vetman assessment

Aurobindo Amoxicillin/Clavulanate

62.5 mg veterinary tablets, 210 tablets for dogs and cats
Assessed clinical scopeDog · Full dog label transferred from the same-strength FDA reference generic: susceptible skin, soft-tissue and periodontal bacterial infections treated with 62.5 mg amoxicillin/clavulanate tablets · By mouth
Care settingOutpatient antimicrobial treatment after diagnosis; culture and susceptibility testing whenever feasible, with comparator-derived clinical claims kept explicit
vetman score 7.1/10 Good
Evidence confidence: Low Georgia: Yes, veterinary · № 286-11 · Verified on 21 Oct 2026

A doseable same-strength generic comparator supports cautious use near whole-tablet weight steps, but exact-product clinical transparency is limited. Culture, narrow-spectrum selection and whole-tablet accuracy are essential.

Regulatory and scientific credibility6.5/10

The exact Aurobindo product is actively registered in Georgia, but no exact public SPC or dossier was found; clinical details rely on a same-strength FDA generic comparator and the Georgian pack description contains ordering defects.

Clinical efficacy7.5/10

The class is effective for susceptible canine skin, soft-tissue and periodontal infections, with bioequivalence evidence for the comparator generic; applicability to this exact Aurobindo presentation is indirect and susceptibility remains decisive.

Safety and tolerability7.5/10

Class safety is established, with gastrointestinal reactions and beta-lactam hypersensitivity as key risks; exact-product and reproductive safety documentation are limited.

Clinical practicality6.5/10

One whole unscored tablet per 4.54 kg every 12 hours is workable only near the printed weight steps; do not split it to create an unvalidated intermediate dose.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use after penicillin or cephalosporin hypersensitivity; serious cross-reactions are possible.
  • The public clinical label is from a same-strength FDA-approved comparator, not an exact Aurobindo SPC; verify the physical pack and leaflet.
  • Treat only a diagnosed susceptible bacterial infection; use culture and susceptibility testing whenever feasible.
  • Use the whole unscored tablet at the printed weight step; do not split it to create an unvalidated dose.
  • Safety in pregnant or breeding animals is not established in the comparator label.
  • Monitor anorexia, lethargy, vomiting, diarrhoea and allergic reactions; report significant adverse events.
  • Prefer the narrowest effective antimicrobial and reassess diagnosis, source control and susceptibility if response is inadequate.
Assessment sources
  1. FDA ANADA 200-7022024
  2. FDA ANADA 200-702 FOI2021
  3. Georgia NFA register 20262026
  4. ISCAID 20252025
  5. ISCAID urinary 20192019
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Full cat label transferred from the same-strength FDA reference generic: susceptible skin, soft-tissue and urinary bacterial infections treated with one 62.5 mg amoxicillin/clavulanate tablet every 12 hours
7.2/10
Good
vetman assessment

Aurobindo Amoxicillin/Clavulanate

62.5 mg veterinary tablets, 210 tablets for dogs and cats
Assessed clinical scopeCat · Full cat label transferred from the same-strength FDA reference generic: susceptible skin, soft-tissue and urinary bacterial infections treated with one 62.5 mg amoxicillin/clavulanate tablet every 12 hours · By mouth
Care settingOutpatient antimicrobial treatment after confirming bacterial disease, with culture and susceptibility testing whenever feasible and comparator-derived claims explicit
vetman score 7.2/10 Good
Evidence confidence: Low Georgia: Yes, veterinary · № 286-11 · Verified on 21 Oct 2026

The fixed feline dose is practical when bacterial infection is confirmed, but exact-product transparency is limited and comparator evidence is not exact-product proof. Avoid treating non-bacterial feline lower urinary disease.

Regulatory and scientific credibility6.5/10

The exact Aurobindo product is actively registered in Georgia, but no exact public SPC or dossier was found; the feline label is transferred from a same-strength FDA generic comparator.

Clinical efficacy7.5/10

The class is established for susceptible feline skin, soft-tissue and urinary infections, but most young cats with lower urinary signs are not bacterially infected; exact-product efficacy evidence is indirect.

Safety and tolerability7.5/10

Class safety is established, with gastrointestinal reactions and beta-lactam hypersensitivity as key risks; exact-product and reproductive safety documentation are limited.

Clinical practicality7.5/10

The label-derived feline regimen is a simple fixed one-tablet dose every 12 hours, but the tablet is unscored and repeated home dosing still requires reliable adherence.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use after penicillin or cephalosporin hypersensitivity; serious cross-reactions are possible.
  • The public clinical label is from a same-strength FDA-approved comparator, not an exact Aurobindo SPC; verify the physical pack and leaflet.
  • Treat only a diagnosed susceptible bacterial infection; use culture and susceptibility testing whenever feasible.
  • Use the whole unscored tablet at the printed weight step; do not split it to create an unvalidated dose.
  • Safety in pregnant or breeding animals is not established in the comparator label.
  • Monitor anorexia, lethargy, vomiting, diarrhoea and allergic reactions; report significant adverse events.
  • Prefer the narrowest effective antimicrobial and reassess diagnosis, source control and susceptibility if response is inadequate.
Assessment sources
  1. FDA ANADA 200-7022024
  2. FDA ANADA 200-702 FOI2021
  3. Georgia NFA register 20262026
  4. ISCAID 20252025
  5. ISCAID urinary 20192019
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Amoxicillin50 mg Clavulanic Acid12.5 mg
Formulation Type
Coated tablet
Administration route
oral
Manufacturer
Aurobindo Pharma Limited · India
Manufacturer (register)
AUROBINDO PHARMA LIMITED, India
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 733, 19 Oct 2026.
Source: NFA veterinary medicines register ↗
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: მოქსიცილინის და კალიუმის კლავულანატის ტაბლეტები 62.5მგ
№ 286-11
Verified on: 21 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
DoseSpeciesWeightRouteFrequencySource
1 tablet
Cats: one complete 62.5 mg tablet every 12 hours. Treat only a susceptible bacterial infection under veterinary direction. Contraindicated after penicillin/cephalosporin allergy; pregnancy/breeding safety is not established. Reported reactions include anorexia, lethargy, vomiting and diarrhoea.
 Cat Any weight By mouth twice daily; duration depends on the susceptible infection
FDA ANADA 200-702
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Amoxicillin and Clavulanate Potassium Veterinary Tablets - FDA ANADA 200-702
DailyMed veterinary label, 2024
1 tablet per 4.536 kg
Give one whole tablet per 10 lb (4.54 kg) body weight every 12 hours (6.25 mg/lb, about 13.78 mg/kg combined active ingredients). The tablet is coated and unscored; the calculator must warn when the exact result requires division. Treat only a susceptible bacterial infection under veterinary direction. Contraindicated after penicillin/cephalosporin allergy; pregnancy/breeding safety is not established. Reported reactions include anorexia, lethargy, vomiting and diarrhoea.
 Dog Any weight By mouth twice daily; duration depends on the susceptible infection
FDA ANADA 200-702
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Amoxicillin and Clavulanate Potassium Veterinary Tablets - FDA ANADA 200-702
DailyMed veterinary label, 2024
375 mg veterinary tablets, Coated tablet · Dog Dog 1 tablet per 27.216 kg
Give one whole tablet per 60 lb (27.22 kg) body weight every 12 hours (6.25 mg/lb, about 13.78 mg/kg combined active ingredients). The tablet is coated and unscored; the calculator must warn when the exact result requires division. Treat only a susceptible bacterial infection under veterinary direction. Contraindicated after penicillin/cephalosporin allergy; pregnancy/breeding safety is not established. Reported reactions include anorexia, lethargy, vomiting and diarrhoea.
 · twice daily; duration depends on the susceptible infection		 twice daily; duration depends on the susceptible infection Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ამოქსიცილინის და კალიუმის კლავულანატის ტაბლეტები 375მგ
№ 240-11
Verified on: 21 Oct 2026
Details: pack, label wording, sources, registration

Aurobindo Amoxicillin/Clavulanate 375 mg veterinary tablets, Coated tablet

210 tablets for dogs
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
7.0/10
Good
vetman assessment

Aurobindo Amoxicillin/Clavulanate

375 mg veterinary tablets, 210 tablets for dogs
Assessed clinical scopeDog · Full dog label transferred from the same-strength FDA reference generic: susceptible skin, soft-tissue and periodontal bacterial infections treated with 375 mg amoxicillin/clavulanate tablets · By mouth
Care settingOutpatient antimicrobial treatment after diagnosis; culture and susceptibility testing whenever feasible, with explicit recognition that the clinical label is comparator-derived
vetman score 7.0/10 Good
Evidence confidence: Low Georgia: Yes, veterinary · № 240-11 · Verified on 21 Oct 2026

A plausible same-strength generic option, but the rating is deliberately restrained because the exact product lacks a public clinical SPC and the unscored 27.22 kg dose step is coarse. Do not treat comparator evidence as exact-product proof.

Regulatory and scientific credibility6.5/10

The exact Aurobindo product is actively registered in Georgia, but no exact public SPC or dossier was found; the dose and clinical scope rely on a same-strength FDA-approved generic comparator, while the Georgian register has a pack-description defect.

Clinical efficacy7.5/10

The class is effective for susceptible canine skin, soft-tissue and periodontal infections, and the comparator generic is bioequivalent to Clavamox; efficacy is indirect for this exact Aurobindo presentation and resistance still limits empirical use.

Safety and tolerability7.5/10

Class and comparator safety are well characterised, with gastrointestinal reactions and beta-lactam hypersensitivity as key concerns, but exact-product safety documentation and reproductive safety are limited.

Clinical practicality6.0/10

One unscored tablet per 27.22 kg every 12 hours creates poor dose granularity for many dogs; the tablet should not be split to manufacture an unvalidated intermediate dose.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use after penicillin or cephalosporin hypersensitivity; serious cross-reactions are possible.
  • The public clinical label is from a same-strength FDA-approved comparator, not an exact Aurobindo SPC; verify the physical pack and leaflet.
  • Treat only a diagnosed susceptible bacterial infection; use culture and susceptibility testing whenever feasible.
  • Use the whole unscored tablet at the printed weight step; do not split it to create an unvalidated dose.
  • Safety in pregnant or breeding animals is not established in the comparator label.
  • Monitor anorexia, lethargy, vomiting, diarrhoea and allergic reactions; report significant adverse events.
  • Prefer the narrowest effective antimicrobial and reassess diagnosis, source control and susceptibility if response is inadequate.
Assessment sources
  1. FDA ANADA 200-7022024
  2. FDA ANADA 200-702 FOI2021
  3. Georgia NFA register 20262026
  4. ISCAID 20252025
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Amoxicillin300 mg Clavulanic Acid75 mg
Formulation Type
Coated tablet
Administration route
oral
Manufacturer
Aurobindo Pharma Limited · India
Manufacturer (register)
AUROBINDO PHARMA LIMITED, India
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 702, 19 Oct 2026.
Source: NFA veterinary medicines register ↗
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ამოქსიცილინის და კალიუმის კლავულანატის ტაბლეტები 375მგ
№ 240-11
Verified on: 21 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
DoseSpeciesWeightRouteFrequencySource
1 tablet per 27.216 kg
Give one whole tablet per 60 lb (27.22 kg) body weight every 12 hours (6.25 mg/lb, about 13.78 mg/kg combined active ingredients). The tablet is coated and unscored; the calculator must warn when the exact result requires division. Treat only a susceptible bacterial infection under veterinary direction. Contraindicated after penicillin/cephalosporin allergy; pregnancy/breeding safety is not established. Reported reactions include anorexia, lethargy, vomiting and diarrhoea.
 Dog Any weight By mouth twice daily; duration depends on the susceptible infection
FDA ANADA 200-702
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Amoxicillin and Clavulanate Potassium Veterinary Tablets - FDA ANADA 200-702
DailyMed veterinary label, 2024
Active substance doses, with sources
Active substance Amoxicillin
Dose calculatorCalculates the active-substance amount; it is not a prescription.
PatientSpecies and weight will be filled in automatically in other calculators.
Selected dose
Dose Species Indication Route Frequency Source
10 mg/kg Dog, Cat Bacterial Infection By mouth 2 times daily
VMD SPC 2025
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Synulox palatable tablets 200 mg/50 mg - Summary of Product Characteristics
UK Veterinary Medicines Directorate, 2025
20 mg/kg Dog Respiratory Tract Infection By mouth 2 times daily
VMD SPC 2025
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Synulox Palatable Drops 40 mg/ml + 10 mg/ml, Powder for Oral Suspension - Summary of Product Characteristics
UK Veterinary Medicines Directorate, 2025
7 mg/kg Dog, Cat Bacterial Infection Subcutaneous once daily for up to 5 days
Betamox 150 mg/ml, VMD SPC 2026
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Betamox 150 mg/ml Suspension for Injection - Summary of Product Characteristics
UK Veterinary Medicines Directorate, 2026
Active substance Clavulanic Acid
Dose calculatorCalculates the active-substance amount; it is not a prescription.
PatientSpecies and weight will be filled in automatically in other calculators.
Selected dose
Dose Species Indication Route Frequency Source
2.5 mg/kg Dog, Cat Bacterial Infection By mouth 2 times daily
VMD SPC 2025
Official product label (SPC), VMD, UK
Approved by the UK Veterinary Medicines Directorate (VMD) as part of the product's authorisation. It applies to that product as authorised there.
Synulox palatable tablets 200 mg/50 mg - Summary of Product Characteristics
UK Veterinary Medicines Directorate, 2025

Known Contraindications

  • Critical Amoxicillin
    Do not use in cases of hypersensitivity to the active substances, other substances of the beta-lactam group or to any of the excipients.
    Sources: VMD SPC · VMD
  • Critical Amoxicillin
    Do not use in animals with severe renal impairment with anuria or oliguria.
    Sources: VMD SPC · VMD
  • Warning Amoxicillin
    The safety of the veterinary medicinal product has not been established during pregnancy and lactation.
    Sources: VMD SPC · VMD
  • Warning Amoxicillin
    The safety of the veterinary medicinal product has not been established during pregnancy and lactation.
    Sources: VMD SPC · VMD

Known Drug Interactions

  • Major warning Amoxicillin + Doxycycline
    The bactericidal effect of amoxicillin may be inhibited by the concomitant use of bacteriostatic antimicrobials.
    Recommendation: If both are required, support the choice with culture and susceptibility results. Otherwise, choose one mechanism.
    Sources: VMD SPC · VMD
  • Major warning Amoxicillin + Oxytetracycline
    Do not give oxytetracycline at the same time as bactericidal antimicrobials such as penicillins or cephalosporins because their antibacterial effects may be antagonistic.
    Recommendation: Do not administer concurrently.
  • Minor warning Amoxicillin + Dihydrostreptomycin
    Penicillins may increase the effect of aminoglycosides.
    Recommendation: An enhanced effect is expected; monitor for aminoglycoside toxicity. Do not mix in the same syringe.
    Sources: VMD SPC · VMD
  • Minor warning Amoxicillin + Trimethoprim/Sulfonamide
    Concurrent use of bactericidal beta-lactam antibiotics and bacteriostatic antimicrobials such as sulfonamides is generally not recommended because their effects may be antagonistic.
    Recommendation: Avoid concomitant administration.

Products are connected by name, active ingredients, or therapeutic group. They are not direct substitutes for one another.

Show all related products (59 more) Hide additional products

Same therapeutic group 59

Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.

For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.

Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.

The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.

This reference is still growing. Missing a product? Let us know. · Report an error or request an addition · Updated: 21 Oct 2026

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.

Register Demo ↗